アレルギー診断の世界市場：洞察、競合情勢、市場予測：2030年

世界のアレルギー診断の市場規模は、2020年に45億8,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に11.78%のCAGRで拡大し、2030年には89億3,000万米ドルに達すると予測されています。アレルギー診断市場は、アレルギー疾患の発生率の急上昇により勢いを増しています。さらに、大気汚染の増加による工業化地域での空気の質の低下など、環境汚染の増加もアレルギー診断薬市場を推進する要因となっています。さらに、技術の進歩や、さまざまなタイプのアレルギーに対応する新しいアレルギー診断検査の発売は、アレルギー診断市場の成長をさらに促進すると予想されます。

アレルギー診断市場の成長に影響を与える主な要因の1つは、アレルギー疾患の罹患率の上昇です。例えば、世界保健機関（WHO）の発表（2023年）によると、2019年には喘息が全世界で2億6,200万人に影響を及ぼしています。さらに、Global Asthma Report（2018）によると、インドでは2018年、成人の約2％、小児の約6％が喘息に苦しんでいます。さらに、別のファクトシートでは、WHOによると、2020年には、薬剤副作用は全入院患者の約3％から6％を占め、そのうち入院患者では約10％から15％、外来処方では約25％の症例が認められました。

さらに、米国喘息・アレルギー・免疫学会（American Academy of Asthma, Allergy &Immunology）によると（2023年）、アレルギー性鼻炎は世界人口の10％から30％が罹患しています。アレルギーは、軽度の増悪から生命を脅かす可能性のあるものまで、さまざまな程度で現れます。そのため、アレルギー検査は、免疫反応を引き起こす可能性のあるアレルゲンを特定する上で重要な役割を果たします。したがって、世界中でアレルギーが増加していることから、アレルギー診断薬に対する需要が高まることが予想されます。これらの検査は、アレルゲンの種類を特定することにより、適切な診断戦略の立案に役立つため、予測期間（2024-2030年）におけるアレルギー診断薬市場の世界の成長を後押しします。

当レポートでは、世界のアレルギー診断市場について調査し、市場の概要とともに、tタイプ別、アレルギータイプ別、診断検査タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 アレルギー診断市場レポートのイントロダクション

第2章 アレルギー診断市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 アレルギー診断市場の主な要因分析

• アレルギー診断市場の促進要因
• アレルギー診断市場の抑制要因と課題
• アレルギー診断市場の機会

第5章 アレルギー診断市場におけるポーターのファイブフォース分析

第6章 アレルギー診断市場に対するCOVID-19の影響分析

第7章 アレルギー診断市場の概要

• タイプ別
• アレルギータイプ別
• 診断検査タイプ別
• エンドユーザー別
• 地域別

第8章 アレルギー診断市場の世界企業シェア分析-主要3～5社

第9章 アレルギー診断市場の企業と製品プロファイル

• Thermo fisher Scientific Inc
• Siemens Helathineers
• Danaher
• Omega Diagnostics Group plc
• HOB Biotech Group Corp Ltd
• Romer Labs Division Holding
• EUROIMMUN Medizinische Labordiagnostika AG
• hollisterStier Allergy
• Eurofins Scientific
• HYCOR Biomedical
• R-Biopharm AG
• AESKU Group GmbH
• ACON Laboratories, Inc
• Lincoln Diagnostics, Inc
• Astra Biotech GmbH
• Erba Group
• Hitachi Chemical Diagnostics Inc
• Hemostasis, LLC
• bioMerieux SA
• PerkinElmer Holdings Ltd

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Allergy Diagnostics Market in Global (2018-2030)
• Table 4: Allergy Diagnostics Market in Global by Type (2018-2030)
• Table 5: Allergy Diagnostics Market in Global by Allergy Type (2018-2030)
• Table 6: Allergy Diagnostics Market in Global by Diagnostic Test Type (2018-2030)
• Table 7: Allergy Diagnostics Market in Global by End User (2018-2030)
• Table 8: Allergy Diagnostics Market in Global by Geography (2018-2030)
• Table 9: Allergy Diagnostics Market in North America (2018-2030)
• Table 10: Allergy Diagnostics Market in North America by Type (2018-2030)
• Table 11: Allergy Diagnostics Market in North America by Allergy Type (2018-2030)
• Table 12: Allergy Diagnostics Market in North America by Diagnostic Test Type (2018-2030)
• Table 13: Allergy Diagnostics Market in North America by End User (2018-2030)
• Table 14: Allergy Diagnostics Market in North America by Country (2018-2030)
• Table 15: Allergy Diagnostics Market in the US (2018-2030)
• Table 16: Allergy Diagnostics Market in Canada (2018-2030)
• Table 17: Allergy Diagnostics Market in Mexico (2018-2030)
• Table 18: Allergy Diagnostics Market in Europe (2018-2030)
• Table 19: Allergy Diagnostics Market in Europe by Type (2018-2030)
• Table 20: Allergy Diagnostics Market in Europe by Allergy Type (2018-2030)
• Table 21: Allergy Diagnostics Market in Europe by Diagnostic Test Type (2018-2030)
• Table 22: Allergy Diagnostics Market in Europe by End User (2018-2030)
• Table 23: Allergy Diagnostics Market in Europe by Country (2018-2030)
• Table 24: Allergy Diagnostics Market in France (2018-2030)
• Table 25: Allergy Diagnostics Market in Germany (2018-2030)
• Table 26: Allergy Diagnostics Market in the United Kingdom (2018-2030)
• Table 27: Allergy Diagnostics Market in Italy (2018-2030)
• Table 28: Allergy Diagnostics Market in Spain (2018-2030)
• Table 29: Allergy Diagnostics Market in Russia (2018-2030)
• Table 30: Allergy Diagnostics Market in Rest of Europe (2018-2030)
• Table 31: Allergy Diagnostics Market in APAC (2018-2030)
• Table 32: Allergy Diagnostics Market in APAC by Type (2018-2030)
• Table 33: Allergy Diagnostics Market in APAC by Allergy Type (2018-2030)
• Table 34: Allergy Diagnostics Market in APAC by Diagnostic Test Type (2018-2030)
• Table 35: Allergy Diagnostics Market in APAC by End User (2018-2030)
• Table 36: Allergy Diagnostics Market in APAC by Country (2018-2030)
• Table 37: Allergy Diagnostics Market in China (2018-2030)
• Table 38: Allergy Diagnostics Market in Japan (2018-2030)
• Table 39: Allergy Diagnostics Market in India (2018-2030)
• Table 40: Allergy Diagnostics Market in Australia (2018-2030)
• Table 41: Allergy Diagnostics Market in South Korea (2018-2030)
• Table 42: Allergy Diagnostics Market in Rest of APAC (2018-2030)
• Table 43: Allergy Diagnostics Market in Rest of World (2018-2030)
• Table 44: Allergy Diagnostics Market in RoW by Type (2018-2030)
• Table 45: Allergy Diagnostics Market in RoW by Allergy Type (2018-2030)
• Table 46: Allergy Diagnostics Market in RoW by Diagnostic Test Type (2018-2030)
• Table 47: Allergy Diagnostics Market in RoW by End User (2018-2030)
• Table 48: Allergy Diagnostics Market in RoW by Region (2018-2030)
• Table 49: Allergy Diagnostics Market in Middle East (2018-2030)
• Table 50: Allergy Diagnostics Market in Africa (2018-2030)
• Table 51: Allergy Diagnostics Market in South America (2018-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Allergy Diagnostics Market in Global (2018-2030)
• Figure 4: Allergy Diagnostics Market in Global by Type (2018-2030)
• Figure 5: Allergy Diagnostics Market in Global by Allergy Type (2018-2030)
• Figure 6: Allergy Diagnostics Market in Global by Diagnostic Test Type (2018-2030)
• Figure 7: Allergy Diagnostics Market in Global by End User (2018-2030)
• Figure 8: Allergy Diagnostics Market in Global by Geography (2018-2030)
• Figure 9: Allergy Diagnostics Market in North America (2018-2030)
• Figure 10: Allergy Diagnostics Market in North America by Type (2018-2030)
• Figure 11: Allergy Diagnostics Market in North America by Allergy Type (2018-2030)
• Figure 12: Allergy Diagnostics Market in North America by Diagnostic Test Type (2018-2030)
• Figure 13: Allergy Diagnostics Market in North America by End User (2018-2030)
• Figure 14: Allergy Diagnostics Market in North America by Country (2018-2030)
• Figure 15: Allergy Diagnostics Market in the US (2018-2030)
• Figure 16: Allergy Diagnostics Market in Canada (2018-2030)
• Figure 17: Allergy Diagnostics Market in Mexico (2018-2030)
• Figure 18: Allergy Diagnostics Market in Europe (2018-2030)
• Figure 19: Allergy Diagnostics Market in Europe by Type (2018-2030)
• Figure 20: Allergy Diagnostics Market in Europe by Allergy Type (2018-2030)
• Figure 21: Allergy Diagnostics Market in Europe by Diagnostic Test Type (2018-2030)
• Figure 22: Allergy Diagnostics Market in Europe by End User (2018-2030)
• Figure 23: Allergy Diagnostics Market in Europe by Country (2018-2030)
• Figure 24: Allergy Diagnostics Market in France (2018-2030)
• Figure 25: Allergy Diagnostics Market in Germany (2018-2030)
• Figure 26: Allergy Diagnostics Market in the United Kingdom (2018-2030)
• Figure 27: Allergy Diagnostics Market in Italy (2018-2030)
• Figure 28: Allergy Diagnostics Market in Spain (2018-2030)
• Figure 29: Allergy Diagnostics Market in Russia (2018-2030)
• Figure 30: Allergy Diagnostics Market in Rest of Europe (2018-2030)
• Figure 31: Allergy Diagnostics Market in APAC (2018-2030)
• Figure 32: Allergy Diagnostics Market in APAC by Type (2018-2030)
• Figure 33: Allergy Diagnostics Market in APAC by Allergy Type (2018-2030)
• Figure 34: Allergy Diagnostics Market in APAC by Diagnostic Test Type (2018-2030)
• Figure 35: Allergy Diagnostics Market in APAC by End User (2018-2030)
• Figure 36: Allergy Diagnostics Market in APAC by Country (2018-2030)
• Figure 37: Allergy Diagnostics Market in China (2018-2030)
• Figure 38: Allergy Diagnostics Market in Japan (2018-2030)
• Figure 39: Allergy Diagnostics Market in India (2018-2030)
• Figure 40: Allergy Diagnostics Market in Australia (2018-2030)
• Figure 41: Allergy Diagnostics Market in South Korea (2018-2030)
• Figure 42: Allergy Diagnostics Market in Rest of APAC (2018-2030)
• Figure 43: Allergy Diagnostics Market in Rest of World (2018-2030)
• Figure 44: Allergy Diagnostics Market in RoW by Type (2018-2030)
• Figure 45: Allergy Diagnostics Market in RoW by Allergy Type (2018-2030)
• Figure 46: Allergy Diagnostics Market in RoW by Diagnostic Test Type (2018-2030)
• Figure 47: Allergy Diagnostics Market in RoW by End User (2018-2030)
• Figure 48: Allergy Diagnostics Market in RoW by Region (2018-2030)
• Figure 49: Allergy Diagnostics Market in Middle East (2018-2030)
• Figure 50: Allergy Diagnostics Market in Africa (2018-2030)
• Figure 51: Allergy Diagnostics Market in South America (2018-2030)
• Figure 52: Market Drivers
• Figure 53: Market Barriers
• Figure 54: Marker Opportunities
• Figure 55: PORTER'S Five Force Analysis

Allergy Diagnostics Market By Type (Products [Instruments And Consumables], And Services), By Allergy Type (Food Allergy, Drug Allergy, Inhalant Alllergy, And Others), By Diagnostic Test Type (In-Vivo And In-Vitro), By End User (Hospitals, Diagnostic Centers, And Others), by geography, is expected to grow at a significant CAGR forecast till 2030 due to the increasing incidence of various allergies such as food allergy and drug allergy as well as growing focus on developing innovative allergy diagnostic products

The global allergy diagnositcs market was valued at USD 4.58 billion in 2020, growing at a CAGR of 11.78% during the forecast period from 2024 to 2030, to reach USD 8.93 billion by 2030. The allergy diagnostics market is gaining momentum owing to the rapidly rising incidence of allergic diseases. Moreover, increasing environmental pollution such as decreasing air quality in industrialized areas due to increasing air pollution is also a factor propelling the allergy diagnostics market. In addition, the technological advancements and the launch of new allergy diangostic tests catering to different types of allergies is further expected to drive the growth of the allergy diangostics market.

Allergy Diagnostics Market Dynamics:

One of the major factors influencing the growth of the allergy diagnostics market is the rising incidence of allergic diseases. For instance, as per the World Health Organization (2023), in 2019, asthma affected 262 million people across the globe. Moreover, as per the Global Asthma Report (2018), in India, in 2018, approximately 2% of adult and 6% of pediatric populations suffered from asthma. Furthermore, in another factsheet, according to the WHO, in the year 2020, adverse drug reactions accounted for about 3% to 6% of all the hospital admissions, of which nearly 10% to 15% of cases were observed in the hospitalized patients and about 25% of the cases in outpatient prescriptions.

Furthermore, as per the American Academy of Asthma, Allergy & Immunology (2023), allergic rhinitis affects between 10% and 30% of the global population. Allergies can manifest in varied degrees from mild exacerbation to potentially life threatening. Therefore, allergy testing can play a key role in identifying potential allergens that may trigger an immune response. Therefore, the increasing number of allergies across the globe is expected to drive the demand for allergy diagnostics as these tests help in identifying the type of allergen thereby helping in devising appropriate diagnostic strategies, thereby boosting the global allergy diagnostics market growth during the forecast period (2024-2030).

Furthermore, deteriorating air quality to several folds due to rapid urbanization have led to a significant increase in the levels of air pollutants such as cigarette smoke, vehicular emission, dust particles, pollens etc. is contributing in the growing cases of allergies associated with air pollution which in turn will lead to the market growth of allergy diagnostics. According to WHO 2022 report, in 2019, approximately 99% of the global population lived in places where air quality standards set by the WHO were not met. Air pollution is linked with the increased incidence of diseases such as allergic rhinitis, asthma, and other allergic disorders. Henceforth, the above-mentioned factors will contribute to the global allergy diagnostics market growth during the forecast period.

However, certain factors such as premium prices associated with allergy diagnostics instruments and lack of awareness about allergic diseases may pose a challenge for the allergy diagnostics market growth.

Along with the above-mentioned factors, the outbreak of the COVID-19 pandemic further acted as a limiting factor for the allergy diagnostics market growth though for a short period. This was due to the reduction in staff such as nurses and continuation of allergy and immunology services across the globe in order to cater to the patient-load associated with the COVID-19 infection which reduced the uptake of allergic diagnostics from pre-COVID levels.

However, with the resumption of activities in the healthcare domain due to the approval of numerous COVID-19 vaccines led to opening up of diagnostic centers and other facilities offering allergic diagnostics, thereby presenting a better growth prospect for the allergy diagnostics market growth.

Allergy Diagnostics Market Segment Analysis:

Allergy Diagnostics Market by Type (Products [Instruments and Consumables], and Services), by Allergy Type (Food Allergy, Drug Allergy, Inhalant Allergy, and Others), by Diagnostic Test (In-Vivo and In-Vitro), by End User (Hospitals, Diagnostic Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the allergy type segment of the allergy diagnostics market, drug allergy category is estimated to account for a significant market share in the allergy diagnostics market. This can be attributed to the rising prevalence of adverse effects arising from different types of medications amongst individuals across the globe. Ths can be supported by the fact that according to the American Academy of Allergy Asthma & Immunology 2022, in 2020, adverse drug reactions accounted for about 10% of the entire world's population including 20% of all the hospitalized patients across the globe. Furthermore, many studies have reported that certain classes of drugs such as antibiotics are common triggers that trigger drug allergy in many patients. Additionally, the American Academy of Asthma, Allergy & Immunology (2023) mentioned that drugs may be responsible for up to 20% of fatalities due to anaphylaxis. Therefore, in order to avoid adverse events associated with drug allergies, allergy diagnostics may play key role in identifying potential unsuitable drugs for patients thereby helping caregivers and doctors devise alternative prognostic routes. Thus, the drug allergy category is expected to account for a significant market share, ultimately driving the allergy diagnostics market during the forecast period.

North America is expected to dominate the overall Allergy Diagnostics Market:

Among all the regions, North America is expected to occupy a major share in the overall allergy diagnostics market during the forecast period. This domination is owing to the increasing incidence of allergies in the region. Additionally, the awareness regarding allergies of various etiologies is significant in the North American region. The presence of key market players in the region as well as the well-established centers offering allergy & immunology services in the region further support the uptake of allergy diagnostic products in the region.

For instance, the growing number of allergy diseases such as food allergy, drug allergy, hay fever and others along with the rising number of manufacturers in the United States is observed to anticipate the demand for allergy diagnostics market in the United States, increasing the overall allergy diagnostics market in the region. For instance, according to the Asthma and Allergy Network Organization in 2020, in the United States, about 6.5% of the children under 18 years of age suffered from food allergy. Also, as per the above-mentioned source in the United States, in 2020, approximately 9.6% of the total population suffered from respiratory allergies in the country. Also, as per the Centers for Disease Control and Prevention, in 2020, the number of people diagnosed with hay fever in the United States was about 19.2 million. All the previously mentioned factors indicate toward the rising patient population suffering from different allergies in the country which correlate to the increase in product demand in the allergy diagnostics market in the United States.

Moreover, the product development activities in terms of new product development, regulatory approvals, and strategic collaborations are also expected to boost the United States allergy diagnostics market in coming years. For instance, in December 2018, Hycor Biomedical Inc. received the regulatory approval from the United States Food and Drug Administration (FDA) for thier new allergy testing system, NOVEOS.

Thus, the interplay of all the aforementioned factors are likely to fuel the market growth of allergy diagnostics in the United States during the forecast period.

Allergy Diagnostics Market Key Players:

Some of the key market players operating in the allergy diagnostics market include HOB Biotech Group Corp., Ltd., Thermofisher Scientific, Siemens Healthineers, Danaher, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, Eurofins Scientific, Omega Diagnostics Group plc, HYCOR Biomedical, R-Biopharm AG, AEKSU GROUP GmbH, ACON Laboratories, Inc, Lincoln Diagnostics, Inc, Astra Biotech GmbH,Erba Group, Hitachi Chemical Diagnostics Inc, Hemostasis Inc, BioMerieux SA, PerkinElmer Holdings Ltd and others.

Recent Developmental Activities in the Allergy Diagnostics Market:

In July 2022, IDS was acquired by PerkinElmer (UK) Holdings Limited wherein the former has product portfolio catering to allergy diagnostics.

In July 2020, Thermofisher Scientific received the regulatory approval from the US FDA for their ImmunoCAP Specific IgE alpha-Gel Allergen Component test for in-vitro use.

In April 2019, Bluejay Diagnostics received the CE mark approval for their allergic conjunctivitis test- Allereye Tear Total IgE Test which is a non-invasive, point-of-care (POC) test for allergic conjunctivitis.

Key Takeaways from the Allergy Diagnostics Market Report Study

• Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the allergy diagnostics market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global allergy diagnostics market.
• Various opportunities available for the other competitor in the allergy diagnostics market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for allergy diagnostics market growth in the coming future?

Target Audience who can be benefited from the Allergy Diagnostics Market Report Study

• Allergy diagnostics providers
• Research organizations and consulting companies
• Allergy diagnostics-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders in Allergy diagnostics
• Various end users who want to know more about the allergy diagnostics market and the latest technological developments in the allergy diagnostics market.

Frequently Asked Questions for the Allergy Diagnostics Market:

1. What is Allergy Diagnostics?

Allergy diagnostics is a broad term that encompasses various devices, instruments, kits, and services that help in identifying the reactive components that are responsible for the anaphylactic reactions in the body.

2. What is the market for Global Allergy Diagnostics?

The global allergy diagnositcs market was valued at USD 4.58 billion in 2020, growing at a CAGR of 11.78% during the forecast period from 2024 to 2030, to reach USD 8.93 billion by 2030.

3. What are the drivers for the Global Allergy Diagnostics?

The allergy diagnostics market is gaining momentum owing to the rapidly rising incidence of allergic diseases. Moreover, increasing environmental pollution such as decreasing air quality in industrialized areas due to increasing air pollution is also a factor propelling the allergy diagnostics market. In addition, the technological advancements and the launch of new allergy diagnostics tests catering to different types of allergies is further expected to drive the growth of the allergy diagnostics market.

4. What are the key players operating in Global Allergy Diagnostics?

Some of the key market players operating in the allergy diagnostics market include HOB Biotech Group Corp., Ltd., Thermofisher Scientific, Siemens Healthineers, Danaher, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, Eurofins Scientific, Omega Diagnostics Group plc, HYCOR Biomedical, R-Biopharm AG, AEKSU GROUP GmbH, ACON Laboratories, Inc, Lincoln Diagnostics, Inc, Astra Biotech GmbH, Erba Group, Hitachi Chemical Diagnostics Inc, Hemostasis Inc, BioMerieux SA, PerkinElmer Holdings Ltd and others.

5. Which region has the highest share in the Allergy Diagnostics market?

Among all the regions, North America is expected to occupy a major share in the overall allergy diagnostics market during the forecast period. This domination is owing to the increasing incidence of allergies in the region. Additionally, the awareness regarding allergies of various etiologies is significant in the North American region. The present of key market players in the region as well as the well-established centers offering allergy & immunology services in the region further support the uptake of allergy diagnostic products in the region.

Table of Contents

1.Allergy Diagnostics Market Report Introduction

2.Allergy Diagnostics Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Allergy Diagnostics Market Key factors analysis

• 4.1. Allergy Diagnostics Market Drivers
  • 4.1.1. Growing incidence of allergic diseases
  • 4.1.2. Increasing levels of pollution across the world
  • 4.1.3. Technological advancements in product development
• 4.2. Allergy Diagnostics Market Restraints and Challenges
  • 4.2.1. Premium costs associated with allergy diagnostic products
  • 4.2.2. Lack of awareness regarding allergies in developing nations
• 4.3. Allergy Diagnostics Market Opportunities
  • 4.3.1. Growth opportunities in low- and middle-income regions
  • 4.3.2. Rising popularity of allergy diagnostic products

5. Allergy Diagnostics Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Allergy Diagnostics Market

7. Allergy Diagnostics Market Layout

• 7.1. By Type
  • 7.1.1. Products
    • 7.1.1.1. Instruments
    • 7.1.1.2. Consumables
  • 7.1.2. Services
• 7.2. By Allergy Type
  • 7.2.1. Food Allergy
  • 7.2.2. Drug Allergy
  • 7.2.3. Inhalant Allergy
  • 7.2.4. Others
• 7.3. By Diagnostic Test Type
  • 7.3.1. In-Vivo
  • 7.3.2. In-Vitro
• 7.4. By End User
  • 7.4.1. Hospitals
  • 7.4.2. Diagnostic Centers
  • 7.3.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. North America Allergy Diagnostics Market, by Type
    • 7.5.1.2. North America Allergy Diagnostics Market, by Allergy Type
    • 7.5.1.3. North America Allergy Diagnostics Market, by Diagnostic Test Type
    • 7.5.1.4. North America Allergy Diagnostics Market, by End User
    • 7.5.1.5. North America Allergy Diagnostics Market, by Country
    • 7.5.1.5.1. United States
    • 7.5.1.5.2. Canada
    • 7.5.1.5.3. Mexico
  • 7.5.2. Europe
    • 7.5.2.1. Europe Allergy Diagnostics Market, by Type
    • 7.5.2.2. Europe Allergy Diagnostics Market, by Allergy Type
    • 7.5.2.3. Europe Allergy Diagnostics Market, by Diagnostic Test Type
    • 7.5.2.4. Europe Allergy Diagnostics Market, by End User
    • 7.5.2.5. Europe Allergy Diagnostics Market, by Country
    • 7.5.2.5.1. France
    • 7.5.2.5.2. Germany
    • 7.5.2.5.3. United Kingdom
    • 7.5.2.5.4. Italy
    • 7.5.2.5.5. Spain
    • 7.5.2.5.6. Russia
    • 7.5.2.5.7. Rest of Europe
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. Asia-Pacific Allergy Diagnostics Market, by Type
    • 7.5.3.2. Asia-Pacific Allergy Diagnostics Market, by Allergy Type
    • 7.5.3.3. Asia-Pacific Allergy Diagnostics Market, by Diagnostic Test Type
    • 7.5.3.4. Asia-Pacific Allergy Diagnostics Market, by End User
    • 7.5.3.5. Asia-Pacific Allergy Diagnostics Market, by Country
    • 7.5.3.5.1. China
    • 7.5.3.5.2. Japan
    • 7.5.3.5.3. India
    • 7.5.3.5.4. Australia
    • 7.5.3.5.5. South Korea
    • 7.5.3.5.6. Rest of Asia Pacific
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. RoW Allergy Diagnostics Market, by Type
    • 7.5.4.2. RoW Allergy Diagnostics Market, by Allergy Type
    • 7.5.4.3. RoW Allergy Diagnostics Market, by Diagnostic Test Type
    • 7.5.4.4. RoW Allergy Diagnostics Market, by End User
    • 7.5.4.5. RoW Allergy Diagnostics Market, by Region
    • 7.5.4.5.1. Middle East
    • 7.5.4.5.2. Africa
    • 7.5.4.5.3. South America

8. Allergy Diagnostics Market Global Company Share Analysis - Key 3-5 Companies

9. Allergy Diagnostics Market Company and Product Profiles

• 9.1. Thermo fisher Scientific Inc
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Siemens Helathineers
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Danaher
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Omega Diagnostics Group plc
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. HOB Biotech Group Corp Ltd
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Romer Labs Division Holding
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. EUROIMMUN Medizinische Labordiagnostika AG
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. hollisterStier Allergy
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Eurofins Scientific
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. HYCOR Biomedical
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. R-Biopharm AG
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. AESKU Group GmbH
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. ACON Laboratories, Inc
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Lincoln Diagnostics, Inc
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Astra Biotech GmbH
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Erba Group
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Hitachi Chemical Diagnostics Inc
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Hemostasis, LLC
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. bioMerieux SA
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. PerkinElmer Holdings Ltd
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us